Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameNational Advisory Council on Drug AbuseAgency NameDepartment of Health and Human Services
Fiscal Year2019Committee Number947
Original Establishment Date10/27/1986Committee StatusChartered
Actual Termination Date Committee URLhttp://www.drugabuse.gov/about-nida/advisory-bo...
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*24
Current Charter Date12/26/2017Designated Fed Officer Position Title*DIRECTOR, DIVISION OF EXTRAMURAL RESEARCH
Date Of Renewal Charter12/26/2019Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*SUSAN
Exempt From Renewal*NoDesignated Federal Officer Middle NameR.B.
Specific Termination AuthorityDesignated Federal Officer Last Name*WEISS
Establishment Authority*Statutory (Congress Created)Designated Federal Officer SuffixPHD
Specific Establishment Authority*42 U.S.C. 284aDesignated Federal Officer Phone*(301) 443-6487
Effective Date Of Authority*11/20/1985Designated Federal Officer Fax*(301) 443-9127
Committee Type*ContinuingDesignated Federal Officer Email*sweiss@nida.nih.gov
Presidential*No
Committee Function*Other Committee
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*Section 492 of the Public Health Service Act states that The Secretary...shall by regulation require appropriate technical and scientific peer review of -(A) applications...; and (B)...biomedical and behavioral research and development contracts... The Council is composed of both scientific and public members who provide the second level of peer review, advise on policy development, program implementation and evaluation, and identify research needs and opportunities of the Institute. The National Advisory Council on Drug Abuse reviewed 5,115 applications requesting $7,354,621,371. The Council approved 7 MERIT awards and 26 administrative supplements.
How is membership balanced?*The National Advisory Council on Drug Abuse is composed of 18 appointed members with research interests and responsibilities paralleling those of the National Institute on Drug Abuse. Twelve members are scientists who are outstanding medical or scientific authorities knowledgeable in the fields of public health and the basic, behavioral or social sciences relevant to the activities of the Institute and six members are representatives of the general public with interests in public policy, law, health policy, economics and management.
How frequent & relevant are cmte mtgs?*Meetings are held not less than three times each fiscal year. This year's meetings were on 2/6/2018, 5/15/2018 and 9/5/2018. The National Advisory Council on Drug Abuse provides advice on a continuing basis on the type of scientific research programs that should be supported and on how to carry out the designated mission and responsibilities of the Institute. It also provides ongoing review of the relevance and effectiveness of the existing programs. Members also participated in other activities on the following dates: 11/7/2017, 11/16/2017, 3/27/2018, and 3/16/2018.
Why advice can't be obtained elsewhere?*The National Advisory Council on Drug Abuse is composed of both scientific and public members who provide the second level of review for research grant applications; advise on policy development, program implementation and evaluation; and identify research needs and opportunities of the Institute. The quality, scope, and balance of advice from this Council cannot be obtained from NIH staff or from other established sources because the membership of the Council is constituted to meet the specific requirements of the mandated mission of the Council and of the Institute.
Why close or partially close meetings?The meetings of the National Advisory Council on Drug Abuse were closed to the public for the review of grant applications. Sections 552b(c)(4) and 552b(c)(6) of the Government in the Sunshine Act permit the closing of meetings where discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Recommendation RemarksCommittee Function: Other - National Scientific and Advisory. This committee did not produce any reports during this reporting period.
The DFO and Committee Decision Maker positions are held by the same individual based on the assignment of responsibilities in the Institute.
Members Andorn, Beirut and Verdin were administratively extended until May 30, 2018. Dr. Volkow was reappointed to serve as Chair.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentNoAction Reallocate ResourcesYes
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingYesAction Approved Grants Or Other PaymentsYes
Outcome Improved Service DeliveryNoAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentNA
Outcome Implement Laws/Reg RequirementsNoGrants Review*Yes
Outcome OtherNoNumber Of Grants Reviewed5,115
Outcome CommentNANumber Of Grants Recommended5,115
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$7,354,621,371.00
Cost Savings CommentNIH supported basic and clinical research accomplishments often take many years to unfold into new diagnostic tests and new ways to treat and prevent diseases.Grants Review CommentNA
Number Of Recommendations*60,468Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentAdvice is given primarily on scientific issues and priorities rather than specific action recommendations.Access Agency WebsiteYes
% of Recs Fully Implemented*0.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentInformation on the research funded by NIH is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentInformation on the research funded by NIH is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.Access OtherNo
Agency Feedback*YesAccess CommentContact the National Institute on Drug Abuse Committee Management Office.
Agency Feedback CommentThe committee receives reports of grants funded and initiatives undertaken.Narrative Description*The goal of NIH research is to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability, from the rarest genetic disorder to the common cold. The NIH mission is to uncover new knowledge that will lead to better health for everyone. NIH works toward that mission by: conducting research in its own laboratories; supporting the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad; helping in the training of research investigators; and fostering communication of medical and health sciences information. Section 492 of the Public Health Service Act states that The Secretary...shall by regulation require appropriate technical and scientific peer review of -(A) applications...; and (B)...biomedical and behavioral research and development contracts... The mission of the National Advisory Council on Drug Abuse is to provide advice to the Director, NIDA on policies and priorities governing support of biomedical and behavioral research at the Institute and to serve as the second level of review for grant applications. The Council meets its mission through open session discussion of policy issues and programmatic initiatives and closed session discussion of individual grant applications.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members* Est Payments to Non-Fed Members Next FY* 
Payments to Federal Members* Est. Payments to Fed Members Next FY* 
Payments to Federal Staff* Estimated Payments to Federal Staff* 
Payments to Consultants* Est. Payments to Consultants Next FY* 
Travel Reimb. For Non-Federal Members* Est Travel Reimb Non-Fed Members nextFY* 
Travel Reimb. For Federal Members* Est Travel Reimb For Fed Members* 
Travel Reimb. For Federal Staff* Est. Travel Reimb to Fed Staff Next FY* 
Travel Reimb. For Consultants* Est Travel Reimb to Consultants Next FY* 
Other Costs Est. Other Costs Next FY* 
Total Costs$0.00Est. Total Next FY*$0.00
Federal Staff Support (FTE)* Est. Fed Staff Support Next FY* 
Hide Section - Custom Links

Custom Links

     Committee Level Reports               
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-002063National Advisory Council on Drug Abuse2017
 COM-002406National Advisory Council on Drug Abuse2016
 COM-003846National Advisory Council on Drug Abuse2015
 COM-004477National Advisory Council on Drug Abuse2014
 COM-006153National Advisory Council on Drug Abuse2013
 COM-006552National Advisory Council on Drug Abuse2012
 COM-008306National Advisory Council on Drug Abuse2011
 COM-008700National Advisory Council on Drug Abuse2010
 COM-010030National Advisory Council on Drug Abuse2009
 COM-010649National Advisory Council on Drug Abuse2008
 COM-012199National Advisory Council on Drug Abuse2007
 COM-012657National Advisory Council on Drug Abuse2006
 COM-013769National Advisory Council on Drug Abuse2005
 COM-014473National Advisory Council on Drug Abuse2004
 COM-015976National Advisory Council on Drug Abuse2003
 COM-016754National Advisory Council on Drug Abuse2002
 COM-017632National Advisory Council on Drug Abuse2001
 COM-018451National Advisory Council on Drug Abuse2000
 COM-019588National Advisory Council on Drug Abuse1999
 COM-020472National Advisory Council on Drug Abuse1998
 COM-021594National Advisory Council on Drug Abuse1997
 COM-034816National Advisory Council on Drug Abuse2018